GRAIL
GRAIL's mission is to detect cancer early, when it can be cured
At GRAIL, our mission is to improve and save lives through early cancer detection, and we are developing our test in a rigorous way to deliver our test to patients safely and effectively.
We need to change the trajectory of cancer mortality and bring stakeholders together to enable broad adoption of innovative, safe, and effective technology that can transform cancer control and cancer care.
Visit website: https://grail.com/
Details last updated 09-Feb-2020
People at GRAIL
Hans Bishop
Chairman of Sana Biotechnology, Chief Executive Officer of GRAIL and President and founder at Altos Labs
GRAIL News
Galleri blood test: a step closer to early cancer detection
BBC - 02-Jun-2023
Offers promising results in the detection, and original site, of over 50 types of cancer in major NHS study
Read more...New study spots cancer tumors in very early stages by simple blood test
Guardian - 25-Jun-2021
Early stage detection of cancer has highest chance of cure
Read more...GRAIL partnered with the NHS to detect cancers early with a simple blood test
GRAIL - 11-Jan-2021
Hopefully this test could be available on the NHS later this year - form an orderly queue!
Read more...Illumina reunites with cancer testing firm Grail, worth $8 billion deal
FierceBiotech - 21-Sep-2020
Marks new era in advancing screening and early diagnosis of cancer technology
Read more...Liquid biopsy detects early signs of cancer
Smithsonian - 07-Feb-2020
Analyzing cancer DNA in blood can present easier diagnosis and more effective treatments
Read more...
